Search clinical trials for: Agalsidase Beta
Total 6009 results
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
ISU Abxis Co., Ltd.RecruitingFabry DiseaseKorea, Republic of
-
Mackay Memorial HospitalRecruiting
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, France, Netherlands, Puerto Rico, United Kingdom
-
Genzyme, a Sanofi CompanyCompleted
-
Ulla Feldt-RasmussenCompleted
-
Genzyme, a Sanofi CompanyWithdrawn
-
Bio Sidus SACompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Hungary, Poland, Czech Republic
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
Bio Sidus SARecruiting
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseCzech Republic, Estonia, Poland, Slovakia
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, France, Poland, United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedFabry Disease | Alpha Galactosidase A DeficiencyUnited States, Austria, United Kingdom
-
Genzyme, a Sanofi CompanyCRL/MedinetTerminatedFabry Disease | Chronic Kidney Disease, Stage IV (Severe)United States
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Czech Republic, Hungary, Poland
-
Amicus TherapeuticsCompletedFabry DiseaseCanada, Belgium, United States, Australia, Netherlands
-
Genzyme, a Sanofi CompanyCompleted
-
ShireCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Netherlands, Hungary, United Kingdom, Czechia, Norway, Slovenia, Spain, Finland, France, Italy, Switzerland
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, Poland, Netherlands, Canada, Argentina, United Kingdom, Norway, Brazil, Czech Republic
-
ShireNo longer available
-
SanofiRecruitingFabry DiseaseItaly, United States, Austria, China, Czechia, Denmark, France, Germany, Greece, Japan, Korea, Republic of, Netherlands, Norway, Spain, Taiwan, Turkey, United Kingdom, Canada, Poland
-
ShireCompleted
-
ShireCompletedFabry DiseaseCanada, United States
-
Baylor Research InstituteNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
National Institute of Neurological Disorders and...CompletedFabry DiseaseUnited States
-
National Institute of Neurological Disorders and...Completed
-
TakedaCompleted
-
ShireCompletedFabry DiseaseUnited States, Slovenia, Australia, Finland, Poland, Czechia, United Kingdom
-
University Hospital, RouenUnknownAnderson-Fabry DiseaseFrance
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
University of Alabama at BirminghamCompletedProteinuria | Fabry DiseaseUnited States, Slovenia
-
Oslo Metropolitan UniversityUniversity of Oslo; Nofima; Mills DACompletedGut Microbiota | Satiety | Post Prandial Blood GlucoseNorway
-
University Hospital, ToulouseCompleted
-
Profil Institut für Stoffwechselforschung GmbHIcahn School of Medicine at Mount Sinai; Heart and Diabetes Center North-Rhine...CompletedType 2 Diabetes MellitusGermany
-
Metabolic Technologies Inc.Koach Sport and NutritionCompletedSurvival TrainingIsrael
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis BrusselUnknown
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Lund UniversityCompleted
-
Instituto de Ciencia y Tecnología de Alimentos...Ministerio de Economía y Competitividad, SpainCompletedInsulin Resistance | Overweight/ObesitySpain
-
Maastricht University Medical CenterCompleted
-
Harokopio UniversityJOTIS S.A. FOOD INDUSTRY, GREECECompleted
-
LifeTime PharmaceuticalsUnknown
-
LifeTime PharmaceuticalsUnknown
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal